November 14-15, 2022 | Washington, DC

Identifying and Advancing Novel Pain Drugs Through Clinical Development and Commercialization

2017 Speaking Faculty

 

Conference Chair

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"][/col] [col class="span3"]

William Schmidt, Ph.D.

President
Northstar Consulting

  

[/col] [/row]

Speaking Faculty

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]

 
  • Laura Bohn, Ph.D.

  • Professor, Departments of Molecular Medicine & Neuroscience
  • The Scripps Research Institute

[/col] [col class="span3"]

  • Nigel Calcutt, Ph.D.

  • Professor, University of California, San Diego
  • Co-Founder, WinSanTor

[/col][col class="span3"]

  • Allen Downs, CLP

  • Senior Corporate & Business Development Lead, Corporate & Business Development
  • Mundipharma International Limited

[/col][col class="span3"]

  • Andre Ghetti, Ph.D.

  • Chief Executive Officer
  • AnaBios Corporation

[/col] [/row]

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]

  • Narender Gavva, Ph.D.

  • Scientific Director
  • Amgen

[/col] [col class="span3"]

  • Geert Jan Groeneveld, MD, Ph.D.

  • Research Director, CNS
  • Centre for Human Drug Research

[/col][col class="span3"]

  • Tilo Grosser, MD

  • Research Associate Professor, Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine
  • University of Pennsylvania

[/col][col class="span3"]

  • Mary Hannaman, MD

  • President, Co-Founder
  • NeuroDigm

[/col] [/row]

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]

  • Sunyoung Kim, D.Phil.

  • Founder and Chief Scientific Officer
  • Viromed

[/col] [col class="span3"]

  • D. Lynn Kirkpatrick, Ph.D.

  • President and CEO
  • Ensysce Biosciences

[/col] [col class="span3"]

  • Sanford J. Madigan, Ph.D.

  • Chief Executive Officer
  • Sova Pharmaceuticals

[/col][col class="span3"]

  • Aashish Manglik, MD, Ph.D.

  • Stanford Distinguished Fellow, Department of Molecular and Cellular Physiology
  • Stanford University School of Medicine

[/col] [/row]

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]

  • Daniel Mikol, MD, Ph.D.

  • Executive Medical Director, Global Neuroscience Development
  • Amgen

[/col] [col class="span3"]

  • Mikhail "Mike" Nemenov, Ph.D.

  • Founder and Chief Scientist, LasMed LLC
  • Senior Research Scholar, Stanford University

[/col] [col class="span3"]

  • Frank Rice, Ph.D.

  • President and Chief Scientist
  • Integrated Tissue Dynamics

[/col] [col class="span3"]

  • Neil Singla, MD

  • Chief Scientific Officer
  • Lotus Clinical Research

[/col] [/row] 

[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]

  • Randall Stevens, MD

  • Chief Medical Officer
  • Centrexion Therapeutics

[/col] [col class="span3"]

  • Simon Tate, Ph.D.

  • Chief Scientific Officer, Convergence Pharmaceuticals
  • Non-Executive Director, Biogen

[/col] [col class="span3"]

  • Tanya Wallace, Ph.D.

  • Head of Biology
  • Blackthorn Therapeutics

[/col] [col class="span3"]

  • Eric Nisenbaum, Ph.D.

  • Group Leader Neurophysiology, Neuroscience Division
  • Eli Lilly and Company

[/col] [/row]

Organized and Produced by

 

Join our Social Media Groups

  
Pain Drug Development Group
                  
@PainConference

Contact Us

For general information about the conference, please contact us at:
This email address is being protected from spambots. You need JavaScript enabled to view it.
+866.945.0263
PO Box 96, Chanhassen, MN 55317 USA

PRIVACY POLICY

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 
READ MORE